Skeletal Fragility in Type 2 Diabetes: Assessment and Management
Skeletal fragility is increasingly recognised as a complication of diabetes, with patients with type 2 diabetes at a higher risk of some fragility fractures. The underlying metabolic contributors to skeletal fragility in T2DM are complex and include obesity, hyperinsulinaemia, hyperglycaemia and advanced glycation end products. Extra considerations are required during the calculation of fracture risk for these patients, as well as for the selection of the most suitable investigations and treatments. Currently available osteoporosis treatments are safe and effective in T2DM.
Modern Medicine – Issue 6 2024.
